US Stock MarketDetailed Quotes

Cyclerion Therapeutics (CYCN)

Watchlist
  • 3.260
  • -0.050-1.51%
Close May 1 15:59 ET
  • 3.010
  • -0.250-7.67%
Post 20:01 ET
14.12MMarket Cap-2.94P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Cyclerion Therapeutics (CYCN) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Total revenue
3.70%2.07M
-43.24%1.03M
351.03%875K
93K
81K
2M
1.81M
194K
0
0
Operating revenue
3.70%2.07M
-43.24%1.03M
351.03%875K
--93K
--81K
--2M
--1.81M
--194K
--0
--0
Cost of revenue
Gross profit
Operating expense
25.21%7.05M
42.87%1.86M
42.28%1.88M
27.53%1.77M
-4.94%1.54M
-41.66%5.63M
-27.35%1.3M
-51.24%1.32M
-25.79%1.38M
-50.60%1.62M
Selling and administrative expenses
13.96%6.09M
7.69%1.34M
23.53%1.53M
33.62%1.71M
-4.57%1.5M
-34.31%5.34M
-29.53%1.25M
-41.76%1.24M
-16.19%1.28M
-41.77%1.57M
-General and administrative expense
13.96%6.09M
7.69%1.34M
23.53%1.53M
33.62%1.71M
-4.57%1.5M
-34.31%5.34M
-29.53%1.25M
-41.76%1.24M
-16.19%1.28M
-41.77%1.57M
Research and development costs
235.31%959K
826.79%519K
329.63%348K
-46.67%56K
-18.18%36K
-81.12%286K
133.33%56K
-86.03%81K
-69.03%105K
-92.31%44K
Operating profit
-37.07%-4.97M
-266.93%-838K
10.82%-1.01M
-20.81%-1.67M
9.95%-1.46M
62.39%-3.63M
127.97%502K
58.39%-1.13M
25.79%-1.38M
50.60%-1.62M
Net non-operating interest income expense
-38.46%128K
39.29%39K
-28.57%30K
-50.00%31K
-63.16%28K
-41.90%208K
-72.28%28K
-60.75%42K
0.00%62K
-13.64%76K
Non-operating interest income
-38.46%128K
39.29%39K
-28.57%30K
-50.00%31K
-63.16%28K
-41.90%208K
-72.28%28K
-60.75%42K
0.00%62K
-13.64%76K
Other net income (expense)
262.81%1.32M
0
1.32M
110.99%363K
0
110.99%363K
Special income (charges)
262.81%1.32M
--0
--0
--1.32M
----
110.99%363K
--0
110.99%363K
----
----
-Less:Impairment of capital assets
----
----
----
----
----
--0
--0
--0
----
----
-Less:Other special charges
-262.81%-1.32M
--0
----
---1.32M
----
---363K
--0
---363K
----
----
Other non- operating income (expenses)
----
----
----
----
----
--363K
--0
--363K
----
----
Income before tax
-15.41%-3.53M
-250.75%-799K
-34.99%-976K
75.49%-324K
7.33%-1.43M
75.72%-3.06M
131.29%530K
87.76%-723K
26.68%-1.32M
51.62%-1.54M
Income tax
Net income
-15.41%-3.53M
-250.75%-799K
-34.99%-976K
75.49%-324K
7.33%-1.43M
41.92%-3.06M
131.29%530K
-109.56%-723K
68.38%-1.32M
77.83%-1.54M
Net income continuous Operations
-15.41%-3.53M
-250.75%-799K
-34.99%-976K
75.49%-324K
7.33%-1.43M
75.72%-3.06M
131.29%530K
87.76%-723K
26.68%-1.32M
51.62%-1.54M
Net income discontinuous operations
----
----
----
----
----
--0
--0
--0
--0
--0
Minority interest income
Net income attributable to the parent company
-15.41%-3.53M
-250.75%-799K
-34.99%-976K
75.49%-324K
7.33%-1.43M
41.92%-3.06M
131.29%530K
-109.56%-723K
68.38%-1.32M
77.83%-1.54M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-15.41%-3.53M
-250.75%-799K
-34.99%-976K
75.49%-324K
7.33%-1.43M
41.92%-3.06M
131.29%530K
-109.56%-723K
68.38%-1.32M
77.83%-1.54M
Basic earnings per share
8.26%-1.11
-186.36%-0.19
-3.45%-0.3
79.25%-0.11
9.68%-0.56
46.22%-1.21
131.43%0.22
-109.35%-0.29
71.04%-0.53
80.63%-0.62
Diluted earnings per share
8.26%-1.11
-186.36%-0.19
-3.45%-0.3
79.25%-0.11
9.68%-0.56
46.22%-1.21
131.43%0.22
-110.66%-0.29
71.04%-0.53
80.63%-0.62
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Total revenue 3.70%2.07M-43.24%1.03M351.03%875K93K81K2M1.81M194K00
Operating revenue 3.70%2.07M-43.24%1.03M351.03%875K--93K--81K--2M--1.81M--194K--0--0
Cost of revenue
Gross profit
Operating expense 25.21%7.05M42.87%1.86M42.28%1.88M27.53%1.77M-4.94%1.54M-41.66%5.63M-27.35%1.3M-51.24%1.32M-25.79%1.38M-50.60%1.62M
Selling and administrative expenses 13.96%6.09M7.69%1.34M23.53%1.53M33.62%1.71M-4.57%1.5M-34.31%5.34M-29.53%1.25M-41.76%1.24M-16.19%1.28M-41.77%1.57M
-General and administrative expense 13.96%6.09M7.69%1.34M23.53%1.53M33.62%1.71M-4.57%1.5M-34.31%5.34M-29.53%1.25M-41.76%1.24M-16.19%1.28M-41.77%1.57M
Research and development costs 235.31%959K826.79%519K329.63%348K-46.67%56K-18.18%36K-81.12%286K133.33%56K-86.03%81K-69.03%105K-92.31%44K
Operating profit -37.07%-4.97M-266.93%-838K10.82%-1.01M-20.81%-1.67M9.95%-1.46M62.39%-3.63M127.97%502K58.39%-1.13M25.79%-1.38M50.60%-1.62M
Net non-operating interest income expense -38.46%128K39.29%39K-28.57%30K-50.00%31K-63.16%28K-41.90%208K-72.28%28K-60.75%42K0.00%62K-13.64%76K
Non-operating interest income -38.46%128K39.29%39K-28.57%30K-50.00%31K-63.16%28K-41.90%208K-72.28%28K-60.75%42K0.00%62K-13.64%76K
Other net income (expense) 262.81%1.32M01.32M110.99%363K0110.99%363K
Special income (charges) 262.81%1.32M--0--0--1.32M----110.99%363K--0110.99%363K--------
-Less:Impairment of capital assets ----------------------0--0--0--------
-Less:Other special charges -262.81%-1.32M--0-------1.32M-------363K--0---363K--------
Other non- operating income (expenses) ----------------------363K--0--363K--------
Income before tax -15.41%-3.53M-250.75%-799K-34.99%-976K75.49%-324K7.33%-1.43M75.72%-3.06M131.29%530K87.76%-723K26.68%-1.32M51.62%-1.54M
Income tax
Net income -15.41%-3.53M-250.75%-799K-34.99%-976K75.49%-324K7.33%-1.43M41.92%-3.06M131.29%530K-109.56%-723K68.38%-1.32M77.83%-1.54M
Net income continuous Operations -15.41%-3.53M-250.75%-799K-34.99%-976K75.49%-324K7.33%-1.43M75.72%-3.06M131.29%530K87.76%-723K26.68%-1.32M51.62%-1.54M
Net income discontinuous operations ----------------------0--0--0--0--0
Minority interest income
Net income attributable to the parent company -15.41%-3.53M-250.75%-799K-34.99%-976K75.49%-324K7.33%-1.43M41.92%-3.06M131.29%530K-109.56%-723K68.38%-1.32M77.83%-1.54M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -15.41%-3.53M-250.75%-799K-34.99%-976K75.49%-324K7.33%-1.43M41.92%-3.06M131.29%530K-109.56%-723K68.38%-1.32M77.83%-1.54M
Basic earnings per share 8.26%-1.11-186.36%-0.19-3.45%-0.379.25%-0.119.68%-0.5646.22%-1.21131.43%0.22-109.35%-0.2971.04%-0.5380.63%-0.62
Diluted earnings per share 8.26%-1.11-186.36%-0.19-3.45%-0.379.25%-0.119.68%-0.5646.22%-1.21131.43%0.22-110.66%-0.2971.04%-0.5380.63%-0.62
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +17.90%
Sample Name
Sample Code
 +13.59%
Sample Name
Sample Code
 +12.81%
4
VanEck Oil Services ETF
OIH
+11.45%
5
United Sts 12 Month Oil Fd Lp Unit Ben Int
USL
+9.96%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +11.87%
Sample Name
Sample Code
 +6.69%
Sample Name
Sample Code
 +6.27%
4
KE Holdings
BEKE
+5.44%
5
New Oriental
EDU
+4.10%
View More
Middle East conflict spreads to the stock market! How should investors respond?
On May 1, the more than two-month-long military conflict involving the US, Israel, and Iran will reach a legal milestone, potentially increa Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -